Are These Canada’s Lowest-Cost Cannabis Producers?

OrganiGram Holdings Inc. (TSXV:OGI)(NASDAQ:OGI) and HEXO Corp. (TSX:HEXO)(NYSE:HEXO) are shaping up as the best ways to play the legalization of cannabis edibles.

| More on:
Marijuana plant and cannabis oil bottles isolated

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

Debate is raging as to whether there are any more substantial gains ahead for Canadian cannabis stocks. The industry has been harshly handled by the market in the wake of Canopy Growth’s shock fiscal 2019 results, an ongoing regulatory investigation at CannTrust, and fears that profitability for many cannabis companies is a long way off.

High costs and lack of profitability

A key concern haunting the industry is that legal cannabis cultivation, processing, and sales may not be as profitable as industry pundits led investors to believe. A key reason for this, aside from the fear the global legal marijuana market may not be as large as initially anticipated, is the cost of producing cannabis in energy-intensive, climate-controlled greenhouses can be enormous.

This has been eating into the profitability of Canadian cultivators with Canopy reporting for fiscal 2019 that it had a total cost of sale, including inventory and biological asset adjustments, of $5.65 per gram of marijuana sold. That had a sharp impact on its gross margin, which, for the period, was 22% or less than half the 48% reported a year earlier.

For those reasons, investors seeking to bolster their exposure to the cannabis industry need to focus on identifying low-cost operators.

One of the lowest-cost cultivators in Canada is OrganiGram (TSXV:OGI)(NASDAQ:OGI). For its fiscal third quarter 2019, it reported cost of sales of $2.70 per gram, or less than half of Canopy’s full-year costs. That saw it reported an impressive gross margin of 50%, which, while 10% lower than the previous quarter, was 2% greater than a year earlier. Those low costs translated into $7.7 million of EBITDA for the quarter and an impressive adjusted EBITDA margin of 31%.

Surprisingly, OrganiGram was able to achieve such low costs, despite using indoor cultivation, supporting its claims that it is not as costly or energy intensive as claimed. The cultivator, however, still reported a net loss of $10.2 million compared to a profit of $2.8 million for the equivalent quarter in 2018. That can be blamed on a sharp increase in costs, including $12.5 million being charged to fair-value changes for biological assets and inventory. Once that charge is included in the cost of sales, that blows out to $5.17 per gram, or almost double the initial amount and only slightly lower the $5.65 per gram reported by Canopy for its fiscal full year 2019.

An even lower-cost producer is HEXO (TSX:HEXO)(NYSE:HEXO). For its fiscal third quarter, it reported that it cost $2.26 per gram of cannabis sold; that could be the lowest reported by Canada’s major cultivators. For that period, HEXO’s net loss ballooned out to $7.8 million, or almost four times greater than a year earlier. This can be attributed to a sharp increase in general and administrative expenses from HEXO focusing on expanding its operations.

Foolish takeaway

Those low costs make OrganiGram and HEXO appealing investments, as does the looming legalization of cannabis edibles and extracts, with both cultivators focused on entering that market. OrganiGram has invested in a facility to manufacture cannabis-infused chocolates with the ability to produce around four million kilograms of chocolates annually.

Meanwhile, HEXO has established a joint venture with brewer Molson Coors to develop non-alcoholic, cannabis-infused beverages. Molson Coors holds a controlling 57.5% interest in the venture with the remainder owned by HEXO.

Analysts believe that edibles in Canada will be worth up to $2.7 billion, and the market will be dominated by cannabis beverages. It is anticipated that edibles, beverages, and other processed recreational cannabis products will have significantly higher margins than dried flower. This means OrganiGram and HEXO, because of their low cannabis production costs, will experience a solid lift in profitability and net income, once they start selling marijuana-infused products.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Matt Smith has no position in any of the stocks mentioned. The Motley Fool owns shares of Molson Coors Brewing.

More on Cannabis Stocks

Retirement plan
Dividend Stocks

4 Stocks That Could Turn $100,000 Into $500,000 by the Time You Retire

Companies such as Brookfield Asset Management have the potential to consistently beat the broader markets and deliver stellar returns to…

Read more »

IMAGE OF A NOTEBOOK WITH TFSA WRITTEN ON IT
Cannabis Stocks

TFSA Investors: 2 U.S. Stocks I’m Never Selling

Canadians looking to diversify their portfolios and gain exposure to U.S. stocks can purchase shares of high-growth companies such as…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis (TSX:ACB) Keeps Burning Cash as Revenue Falls

Aurora Cannabis (TSX:ACB)(NASDAQ:ACB) is still losing money. Its revenue is declining, too.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

Why Canopy Growth Stock Climbed as Much as 20% on Monday

A glimmer of hope from the U.S. Congress may lead to renewed interest in marijuana investing.

Read more »

TSX Today
Cannabis Stocks

TSX Today: What to Watch for in Stocks on Friday, July 15

A continued selloff in metals prices is likely to pressure the commodity-heavy TSX Composite benchmark at the open today.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

With the Cannabis Industry Trading Ultra-Cheap, Organigram Stock Looks Like a Screaming Buy!

After selling off for years, Organigram stock now offers tonnes of value and is easily one of the best cannabis…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Canopy Growth Stock: The Only Cannabis Stock to Consider Long Term

The cannabis stock industry remains an incredibly high risk one, but Canopy Growth (TSX:WEED)(NYSE:CGC) stock provides the best opportunity for…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Should You Stay Away From HEXO Stock?

HEXO (TSX:HEXO)(NASDAQ:HEXO) stock is on a downward spiral, and there is little hope it is going to recover soon.

Read more »